中国临床医学
中國臨床醫學
중국림상의학
CLINICAL MEDICAL JOURNAL OF CHINA
2015年
2期
186-188
,共3页
楼丽娜%陈炼%沈菁原%曹琳%倪琦%陈芳
樓麗娜%陳煉%瀋菁原%曹琳%倪琦%陳芳
루려나%진련%침정원%조림%예기%진방
脑钠肽%慢性充血性心力衰竭%肺源性心脏病%鉴别诊断%治疗评估
腦鈉肽%慢性充血性心力衰竭%肺源性心髒病%鑒彆診斷%治療評估
뇌납태%만성충혈성심력쇠갈%폐원성심장병%감별진단%치료평고
Brain natriuretic peptide%Chronic congestive heart failure%Cor pulmonale%Differential diagnosis%Therapeutic effect assessment
目的:探讨高血压伴慢性左心衰竭患者与慢性阻塞性肺病(chronic obstructive pulmonary disease ,COPD)合并肺源性心脏病(cor pulmonale ,CP)患者的血浆脑钠肽(brain natriuretic peptide ,BNP)的变化及其对治疗评估的价值。方法:以上海市第二人民医院2010年11月—2013年11月收治的高血压伴慢性左心衰竭患者36例、COPD伴CP患者34例为研究对象,并同时选择心肺功能正常者30例作为对照组。定量检测治疗前后各组的血浆BNP水平。结果:高血压伴慢性左心衰竭组及COPD伴CP组治疗前血浆BNP水平均高于对照组(P<0.05),治疗前高血压伴慢性左心衰竭组血浆BNP水平高于COPD伴CP组(P<0.05);治疗后高血压伴慢性左心衰竭组和COPD伴CP组血浆BNP水平均较治疗前下降(P<0.05),高血压伴慢性左心衰竭组血浆BNP水平高于COPD伴CP组(P<0.05)。结论:BNP可作为CP和慢性左心衰竭的鉴别诊断及治疗评估指标。
目的:探討高血壓伴慢性左心衰竭患者與慢性阻塞性肺病(chronic obstructive pulmonary disease ,COPD)閤併肺源性心髒病(cor pulmonale ,CP)患者的血漿腦鈉肽(brain natriuretic peptide ,BNP)的變化及其對治療評估的價值。方法:以上海市第二人民醫院2010年11月—2013年11月收治的高血壓伴慢性左心衰竭患者36例、COPD伴CP患者34例為研究對象,併同時選擇心肺功能正常者30例作為對照組。定量檢測治療前後各組的血漿BNP水平。結果:高血壓伴慢性左心衰竭組及COPD伴CP組治療前血漿BNP水平均高于對照組(P<0.05),治療前高血壓伴慢性左心衰竭組血漿BNP水平高于COPD伴CP組(P<0.05);治療後高血壓伴慢性左心衰竭組和COPD伴CP組血漿BNP水平均較治療前下降(P<0.05),高血壓伴慢性左心衰竭組血漿BNP水平高于COPD伴CP組(P<0.05)。結論:BNP可作為CP和慢性左心衰竭的鑒彆診斷及治療評估指標。
목적:탐토고혈압반만성좌심쇠갈환자여만성조새성폐병(chronic obstructive pulmonary disease ,COPD)합병폐원성심장병(cor pulmonale ,CP)환자적혈장뇌납태(brain natriuretic peptide ,BNP)적변화급기대치료평고적개치。방법:이상해시제이인민의원2010년11월—2013년11월수치적고혈압반만성좌심쇠갈환자36례、COPD반CP환자34례위연구대상,병동시선택심폐공능정상자30례작위대조조。정량검측치료전후각조적혈장BNP수평。결과:고혈압반만성좌심쇠갈조급COPD반CP조치료전혈장BNP수평균고우대조조(P<0.05),치료전고혈압반만성좌심쇠갈조혈장BNP수평고우COPD반CP조(P<0.05);치료후고혈압반만성좌심쇠갈조화COPD반CP조혈장BNP수평균교치료전하강(P<0.05),고혈압반만성좌심쇠갈조혈장BNP수평고우COPD반CP조(P<0.05)。결론:BNP가작위CP화만성좌심쇠갈적감별진단급치료평고지표。
Objective:To investigate the variation of plasma braln natriuretic peptide(BNP) and its value for diagnosis and treatment in patients with hypertension accompanied by chronic left heart fallure or chronic obstructive pulmonary disease (COPD) accompanied by cor pulmonale(CP) .Methods:A total of 36 patients with hypertension accompanied by chronic left heart fallure and 34 patients with COPD accompanied by CP ,who were admitted to Shanghal Second People’s Hospital from Nov 2010 to Nov 2013 ,were enrolled as study subjects .Meanwhile ,30 normal control were enrolled .Quantitative detection of plasma BNP level was done in each group before and after the treatment .Results:The levels of plasma BNP in the hypertension accompanied by chronic left heart fallure group and the COPD accompanied by CP group before the treatment were higher than that in the control group(P<0 .05) .The levels of plasma BNP in the hypertension accompanied by chronic left heart fallure group was higher than that in the COPD accompanied by CP group before the treatment(P< 0 .05) .After the treatment ,the levels of plasma BNP in both the hypertension accompanied by chronic left heart fallure group and the COPD accompanied by CP group decreased (P<0 .05) .The level of plasma BNP in the hypertension accompanied by chronic left heart fallure group was higher than that in the COPD accompanied by CP group after the treatment(P<0 .05) .Conclusions:BNP can be used as the index for differential diagnosis and therapeutic effect assessment of CP and chronic left heart fallure .